Literature DB >> 2970636

Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease.

B Wolozin1, A Scicutella, P Davies.   

Abstract

ALZ-50 is a monoclonal antibody that recognizes a protein of apparent molecular mass 68 kilodaltons (A68). The protein is present in the brains of patients with Alzheimer disease but is not detectable in normal adult brain tissue. We now report that ALZ-50-reactive neurons are found in normal fetal and neonatal human brain and in brain tissue from neonatal individuals with Down syndrome. Reactive neurons decrease sharply in number after age 2 and reappear in older individuals with Down syndrome and in patients with Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970636      PMCID: PMC281933          DOI: 10.1073/pnas.85.16.6202

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

Review 1.  Down's syndrome and Alzheimer's dementia: defining an association.

Authors:  L L Heston
Journal:  Psychiatr Dev       Date:  1984

2.  Differential localization of MAP-2 and tau in mammalian neurons in situ.

Authors:  L I Binder; A Frankfurter; L I Rebhun
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

3.  A neuronal antigen in the brains of Alzheimer patients.

Authors:  B L Wolozin; A Pruchnicki; D W Dickson; P Davies
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

4.  Microtubule-associated proteins in the developing brain.

Authors:  A Matus; B Riederer
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

5.  Studies of the earliest generated cells of the cat's visual cortex: cogeneration of subplate and marginal zones.

Authors:  M B Luskin; C J Shatz
Journal:  J Neurosci       Date:  1985-04       Impact factor: 6.167

6.  The differential appearance of neurofilament triplet polypeptides in the developing rat optic nerve.

Authors:  J S Pachter; R K Liem
Journal:  Dev Biol       Date:  1984-05       Impact factor: 3.582

7.  Cytology and time of origin of interstitial neurons in the white matter in infant and adult human and monkey telencephalon.

Authors:  I Kostovic; P Rakic
Journal:  J Neurocytol       Date:  1980-04

8.  Transient cells of the developing mammalian telencephalon are peptide-immunoreactive neurons.

Authors:  J J Chun; M J Nakamura; C J Shatz
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

9.  The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.

Authors:  P C Burger; F S Vogel
Journal:  Am J Pathol       Date:  1973-11       Impact factor: 4.307

10.  Alz-50 antibody recognizes Alzheimer-related neuronal changes.

Authors:  B T Hyman; G W Van Hoesen; B L Wolozin; P Davies; L J Kromer; A R Damasio
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

View more
  10 in total

1.  Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. Demonstration using the hydrated autoclaving method.

Authors:  R W Shin; T Iwaki; T Kitamoto; Y Sato; J Tateishi
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

2.  Expression of a unique 56-kDa polypeptide by neurons in the subplate zone of the developing cerebral cortex.

Authors:  J R Naegele; C J Barnstable; P R Wahle
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

3.  An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

Authors:  N W Kowall; M F Beal; J Busciglio; L K Duffy; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus.

Authors:  I Ferrer; F Gullotta
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751.

Authors:  L S Higgins; J M Rodems; R Catalano; D Quon; B Cordell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Immunohistological study on brains of Alzheimer's disease using antibodies to fetal antigens, C-series gangliosides and microtubule-associated protein 5.

Authors:  H Takahashi; K Hirokawa; S Ando; K Obata
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients.

Authors:  K Nihei; A C McKee; N W Kowall
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Thyroid function and plasma immunoglobulins in subjects with Down's syndrome (DS) during ontogenesis and zinc therapy.

Authors:  M Sustrová; V Strbák
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

9.  Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue.

Authors:  S M de la Monte; R A Spratt; J Chong; H A Ghanbari; J R Wands
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

10.  Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

Authors:  D W Dickson; H Crystal; L A Mattiace; Y Kress; A Schwagerl; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.